BofA Securities Downgrades Rhythm Pharmaceuticals (RYTM) to Neutral

November 30, 2020 6:03 AM EST
Get Alerts RYTM Hot Sheet
Price: $21.50 +3.46%

Rating Summary:
    6 Buy, 1 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 10 | Down: 9 | New: 61
Trade Now! 
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

BofA Securities downgraded Rhythm Pharmaceuticals (NASDAQ: RYTM) from Buy to Neutral with a price target of $33.00.


For an analyst ratings summary and ratings history on Rhythm Pharmaceuticals click here. For more ratings news on Rhythm Pharmaceuticals click here.


Shares of Rhythm Pharmaceuticals closed at $29.27 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Downgrades